Koichiro Inaki
About
Koichiro Inaki is a scholar working on Oncology, Molecular Biology and Cancer Research.
According to data from OpenAlex, Koichiro Inaki has authored 21 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Koichiro Inaki's work include Cancer Genomics and Diagnostics (6 papers), Colorectal Cancer Treatments and Studies (5 papers) and Gastric Cancer Management and Outcomes (5 papers). Koichiro Inaki is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Colorectal Cancer Treatments and Studies (5 papers) and Gastric Cancer Management and Outcomes (5 papers). Koichiro Inaki collaborates with scholars based in Japan, United States and United Kingdom. Koichiro Inaki's co-authors include Tatsuya Haga, Kazushige Touhara, Hiroshi Kataoka, Kentaro Kajiya, Motonari Tanaka, Edison T. Liu, Akio Tsuboi, Takaaki Sato, Hitoshi Sakano and Junzo Hirono and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.
In The Last Decade
Koichiro Inaki
21 papers receiving 859 citations
Peers
Koichiro Inaki
Staffan Bohm Sweden
Michinori Kitagawa Japan
Joyce W. Margolis United States
Dominique Eggerickx Belgium
Pedro J. Andrés-Barquin United States
Ariane Baudhuin United States
Giovanni Pascarella Italy
James C. Walker United States
Chikako Yamada Japan
Anna Sczaniecka United States
Citations per year, relative to Koichiro Inaki Koichiro Inaki (= 1×)
peers
Staffan Bohm
Countries citing papers authored by Koichiro Inaki
Since
Specialization
Citations
This map shows the geographic impact of Koichiro Inaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koichiro Inaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koichiro Inaki more than expected).
Fields of papers citing papers by Koichiro Inaki
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Koichiro Inaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koichiro Inaki. The network helps show where Koichiro Inaki may publish in the future.
Co-authorship network of co-authors of Koichiro Inaki
This figure shows the co-authorship network connecting the top 25 collaborators of Koichiro Inaki. A scholar is included among the top collaborators of Koichiro Inaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koichiro Inaki. Koichiro Inaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Siena, Salvatore, Kanwal Raghav, Toshiki Masuishi, et al.. (2024). HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01. Nature Communications. 15(1). 10213–10213.
2.
Failmezger, Henrik, Jessica Chan, Anatoliy Shumilov, et al.. (2023). Computational pathology–based HER2 quantification to identify novel biomarkers in gastric cancer (GC).. Journal of Clinical Oncology. 41(4_suppl). 449–449.
3.
Shitara, Kohei, Yung‐Jue Bang, Satoru Iwasa, et al.. (2022). Exploratory analysis of the impact of prior immune checkpoint inhibitor (ICI) on trastuzumab deruxtecan (T-DXd; DS-8201) clinical outcomes and biomarkers (BM) in DESTINY-Gastric01 (DG-01), a randomized, phase 2, multicenter, open-label study in patients (pts) with HER2+ advanced gastric or gastroesophageal junction adenocarcinoma.. Journal of Clinical Oncology. 40(4_suppl). 322–322.
4.
Inaki, Koichiro, Tomoko Shibutani, Naoyuki Maeda, et al.. (2022). Pan-cancer gene expression analysis of tissue microarray using EdgeSeq oncology biomarker panel and a cross-comparison with HER2 and HER3 immunohistochemical analysis. PLoS ONE. 17(9). e0274140–e0274140.
5.
Siena, Salvatore, Kanwal Raghav, Toshiki Masuishi, et al.. (2021). 386O Exploratory biomarker analysis of DESTINY-CRC01, a phase II, multicenter, open-label study of trastuzumab deruxtecan (T-DXd, DS-8201) in patients (pts) with HER2-expressing metastatic colorectal cancer (mCRC). Annals of Oncology. 32. S532–S532.
6.
Kagiyama, Yuki, Yutaka Shima, Kazutsune Yamagata, et al.. (2021). CDKN1C‐mediated growth inhibition by an EZH1/2 dual inhibitor overcomes resistance of mantle cell lymphoma to ibrutinib. Cancer Science. 112(6). 2314–2324.
7.
Shitara, Kohei, Yung‐Jue Bang, Satoru Iwasa, et al.. (2021). O-14 Exploratory biomarker analysis of trastuzumab deruxtecan in DESTINY-Gastric01, a randomized, phase 2, multicenter, open-label study in patients with HER2-positive or -low advanced gastric or gastroesophageal junction adenocarcinoma. Annals of Oncology. 32. S224–S224.
8.
Banjo, Toshihiro, Daisuke Honma, Yoshimi Takata, et al.. (2019). Anti-Tumor Effect of the EZH1/2 Dual Inhibitor Valemetostat Against Diffuse Large B-Cell Lymphoma Via Modulation of B-Cell Receptor Signaling and c-Myc Signaling Pathways. Blood. 134(Supplement_1). 4642–4642.
9.
Seki, Takehito, Nobuaki Adachi, Hirofumi Sumi, et al.. (2019). PF225 AZACITIDINE (AZA) ENHANCES ANTILEUKEMIC ACTIVITY OF THE MDM2 INHIBITOR MILADEMETAN IN TP53 WILD-TYPE ACUTE MYELOID LEUKEMIA (AML). HemaSphere. 3(S1). 65–65.
10.
Nakagawa, Makoto, Takuo Katsumoto, Kazutsune Yamagata, et al.. (2018). Dual inhibition of enhancer of zeste homolog 1/2 overactivates WNT signaling to deplete cancer stem cells in multiple myeloma. Cancer Science. 110(1). 194–208.
11.
Jimbo, Takahiro, Naoyuki Maeda, Noriyasu Haginoya, et al.. (2017). P3.02-042 DS-1205b, a Novel, Selective, Inhibitor of AXL, Delays the Onset of Resistance and Overcomes Acquired Resistance to EGFR-TKIs. Journal of Thoracic Oncology. 12(11). S2252–S2252.
12.
Nakagawa, Makoto, Daisuke Honma, Kazushi Araki, et al.. (2017). Novel Stem Cell-Targeted Therapy for Multiple Myeloma Based on Dual Inhibition of EZH1/2. Blood. 130. 590.
13.
Jimbo, Takahiro, Naoyuki Maeda, Noriyasu Haginoya, et al.. (2017). DS-1205b, a novel, selective, small-molecule inhibitor of AXL, delays the onset of resistance and overcomes acquired resistance to EGFR-TKIs in a human EGFR-mutant NSCLC (T790M-negative) xenograft model. Annals of Oncology. 28. v132–v132.
14.
Menghi, Francesca, Koichiro Inaki, Pooja Kumar, et al.. (2016). The tandem duplicator phenotype as a distinct genomic configuration in cancer. Proceedings of the National Academy of Sciences. 113(17). E2373–82.
15.
Inaki, Koichiro, Francesca Menghi, Xing Yi Woo, et al.. (2014). Systems consequences of amplicon formation in human breast cancer. Genome Research. 24(10). 1559–1571.
16.
Grzȩda, Krzysztof R., Béryl Royer‐Bertrand, Koichiro Inaki, et al.. (2014). Functional chromatin features are associated with structural mutations in cancer. BMC Genomics. 15(1). 1013–1013.
17.
Inaki, Koichiro & Edison T. Liu. (2012). Structural mutations in cancer: mechanistic and functional insights. Trends in Genetics. 28(11). 550–559.
18.
Inaki, Koichiro, Sachiko Nishimura, Toshiaki Nakashiba, Shigeyoshi Itohara, & Yoshihiro Yoshihara. (2004). Laminar organization of the developing lateral olfactory tract revealed by differential expression of cell recognition molecules. The Journal of Comparative Neurology. 479(3). 243–256.
19.
Inaki, Koichiro, Yûji Takahashi, Shin Nagayama, & Kensaku Mori. (2002). Molecular‐feature domains with posterodorsal–anteroventral polarity in the symmetrical sensory maps of the mouse olfactory bulb: mapping of odourant‐induced Zif268 expression. European Journal of Neuroscience. 15(10). 1563–1574.
20.
Kajiya, Kentaro, Koichiro Inaki, Motonari Tanaka, et al.. (2001). Molecular Bases of Odor Discrimination: Reconstitution of Olfactory Receptors that Recognize Overlapping Sets of Odorants. Journal of Neuroscience. 21(16). 6018–6025.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Staffan Bohm Breakdown of academic impact, for papers by Michinori Kitagawa Breakdown of academic impact, for papers by Joyce W. Margolis Breakdown of academic impact, for papers by Dominique Eggerickx Breakdown of academic impact, for papers by Pedro J. Andrés-Barquin Breakdown of academic impact, for papers by Ariane Baudhuin Breakdown of academic impact, for papers by Giovanni Pascarella Breakdown of academic impact, for papers by James C. Walker Breakdown of academic impact, for papers by Chikako Yamada Breakdown of academic impact, for papers by Anna Sczaniecka